9:40 AM
 | 
Apr 12, 2019
 |  BC Extra  |  Company News

BMS, Celgene shareholders approve acquisition

Editor's Note: This article was updated on Apr 12, 2019 at 1:39 PM PDT

Shareholders from both BMS and Celgene voted Friday to approve the pharma's acquisition of the biotech for $74 billion in a cash and stock...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >